Literature DB >> 15377288

Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma.

Keishi Fujiwara1, Toshihiro Higashi, Kazuhiro Nouso, Harushige Nakatsukasa, Yoshiyuki Kobayashi, Masayuki Uemura, Shin-Ichiro Nakamura, Shuichiro Sato, Tadashi Hanafusa, Yasuhiro Yumoto, Ichiro Naito, Yasushi Shiratori.   

Abstract

BACKGROUND AND AIM: We analyzed the expression of antigen-processing and antigen-presenting molecules in surgically resected fresh samples of human hepatocellular carcinoma (HCC) tissue to elucidate a mechanism of immune escape. We also examined the expression of interleukin (IL)-10 protein, which might act to downregulate expression of antigen-processing and antigen-presenting molecules.
METHODS: Twenty-eight HCC samples obtained by surgical resection were analyzed for the expression of beta2-microglobulin, heat-shock protein (HSP)-70, human leukocyte antigen (HLA) class-I, CD80 (B7-1), CD86 (B7-2) and IL-10 by immunostaining.
RESULTS: Beta2-microglobulin and HSP-70 were preserved in all samples. In contrast, the expression of HLA class-I molecules was significantly reduced according to lowering in the histological grading of tumor differentiation (P = 0.024). Furthermore, B7-1 and B7-2 expression was reduced in tumor cells compared with corresponding areas of liver tissue without malignant involvement irrespective of the histological grading of tumors (21% and 36%, respectively). Although IL-10 protein was expressed in 54% of HCC, no relationship between the expression of IL-10 and downregulation of B7-1, B7-2, and HLA class-I was evident.
CONCLUSION: These findings suggest the potential role of B7 co-stimulatory molecules and HLA class-I molecules in facilitating HCC escape from immune surveillance without the involvement of IL-10.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377288     DOI: 10.1111/j.1440-1746.2004.03467.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  17 in total

Review 1.  Potentiality of immunotherapy against hepatocellular carcinoma.

Authors:  Nobuhiro Tsuchiya; Yu Sawada; Itaru Endo; Yasushi Uemura; Tetsuya Nakatsura
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

2.  Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma.

Authors:  Guoqiang Li; Xiaofeng Wu; Feng Zhang; Xiangcheng Li; Beicheng Sun; Yue Yu; Aihong Yin; Lei Deng; Jie Yin; Xuehao Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-19       Impact factor: 4.553

3.  Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma.

Authors:  Miriam Alb; Christopher Sie; Christian Adam; Suzie Chen; Jürgen C Becker; David Schrama
Journal:  Cancer Immunol Immunother       Date:  2012-06-07       Impact factor: 6.968

4.  B7 molecule mRNA expression in colorectal carcinoma.

Authors:  Ju-Xiang Xiao; Pei-Song Bai; Bao-Chang Lai; Li Li; Juan Zhu; Yi-Li Wang
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

5.  Mesenchymal stem cells avoid allogeneic rejection.

Authors:  Jennifer M Ryan; Frank P Barry; J Mary Murphy; Bernard P Mahon
Journal:  J Inflamm (Lond)       Date:  2005-07-26       Impact factor: 4.981

6.  Effects of costimulation on intrahepatic immunopathogenesis in patients with chronic HBV infection.

Authors:  Bei Zhong; Mao Ping Huang; Guo Qing Yin; Xiang Gao
Journal:  Inflamm Res       Date:  2013-12-14       Impact factor: 4.575

Review 7.  The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.

Authors:  Gaetano Bertino; Shirin Demma; Annalisa Ardiri; Maria Proiti; Alessandra Mangia; Salvatore Gruttadauria; Adriana Toro; Isidoro Di Carlo; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Michele Malaguarnera
Journal:  Biomed Res Int       Date:  2015-03-29       Impact factor: 3.411

Review 8.  Immunotherapy for liver tumors: present status and future prospects.

Authors:  Pablo Matar; Laura Alaniz; Viviana Rozados; Jorge B Aquino; Mariana Malvicini; Catalina Atorrasagasti; Manuel Gidekel; Marcelo Silva; O Graciela Scharovsky; Guillermo Mazzolini
Journal:  J Biomed Sci       Date:  2009-03-06       Impact factor: 8.410

Review 9.  Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies.

Authors:  Gaetano Bertino; Shirin Demma; Annalisa Ardiri; Maria Proiti; Salvatore Gruttadauria; Adriana Toro; Giulia Malaguarnera; Nicoletta Bertino; Michele Malaguarnera; Mariano Malaguarnera; Isidoro Di Carlo
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

Review 10.  Adaptive immunity in the liver.

Authors:  Zongwen Shuai; Miranda Wy Leung; Xiaosong He; Weici Zhang; Guoxiang Yang; Patrick Sc Leung; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2016-03-21       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.